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A B S T R A C T
Tuberculosis (TB) is an infectious disease caused by the aerobic microbe Mycobacterium tuberculosis
H37Rv. Despite the availability of the Bacille Calmette–Gue´rin (BCG) vaccine and directly observed
treatment, short-course (DOTS), TB is a leading cause of death and affects a third of the world’s
population. The most important factor associated with disease severity is the development of antibiotic-
resistant strains, including multidrug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB. In
order to understand disease pathogenesis, it is necessary to delineate the speciﬁc features of M.
tuberculosis that enable it to evade the host defense system and contribute to its virulence. Here, we have
reviewed the various characteristics, such as cell wall components, virulence genes, and the role of small
guanosine triphosphatases (GTPases) in the pathogenesis of TB. GTPases are known to play a crucial role
in the survival and pathogenesis of various pathogens. The key role of these proteins involves
interference in phagosomematuration arrest, enabling pathogens to survive by escaping from lysozymes
and toxic free radicals. This observation provides a new avenue for the development of anti-TB drugs.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Tuberculosis (TB) is a leading cause of mortality and affects one
third of the world’s population. This is a common and most deadly
infectious disease, which spreads through the air when an affected
person coughs, sneezes, or spits. It mainly attacks the lungs, but
can also affect the central nervous system, lymphatic system,
circulatory system, genitourinary system, gastrointestinal system,
bones, joints, and skin.1 A number of treatment and preventive
strategies have been implemented over the last 50 years, with the
Bacille Calmette–Gue´rin (BCG) vaccine being themost widely used
against TB. Some antibiotics, such as rifampin and isoniazid, are
also employed in the treatment of TB. However, spontaneous
mutation, incomplete and inadequate treatment, poor administra-
tive control, and irregular distribution of drugs have led to the
development of multidrug-resistant (MDR)-TB, progressing to
extensively drug-resistant (XDR)-TB.2
Mycobacterium tuberculosis H37Rv is a unique acid-fast Gram-
positive bacterium; it neither contains a phospholipid outer
membrane nor retains dye due to the high lipid and mycolic acid
content of its cell wall. TheM. tuberculosis H37Rv cell wall contains
large amounts of glycolipid and is especially rich in mycolic acid,
peptidoglycan, lipoarabinomannan (LAM), phosphatidylinositol
mannosides (PIM), phthiocerol dimycocerosate, cord factor,
sulfolipids, and wax D (Figure 1).3–7* Corresponding author. Tel.: +91 11 27666156; fax: +91 11 27667471.
E-mail addresses: meena@igib.res.in, Laxmansm72@yahoo.com (L.S. Meena).
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a number of genes conferring survival and persistence within the
host. It manipulates host defense pathways resulting in inhibition
of apoptosis of infected host cells. These virulence genes include
nuoG, erp, phospholipases c, and fadE28.8–14
In the past few years, extensive work has been done to
understand the role of guanosine triphosphatases (GTPases) in the
growth and development of bacteria. GTPases are also known as
molecular switch proteins.15 These proteins speciﬁcally bind and
hydrolyze GTP, which in turn activates or inactivates the GTPase in
a cyclic manner (Figure 2).15 GTPases are highly conserved and
function through RNA or ribosome binding. G1, G2, G3, and G4
motifs are responsible for speciﬁc interactions with the guanine
nucleotide and effector proteins. Genome sequencing projects
have revealed a core of 11 universally conserved GTPases, referred
to as elongation factors G and Tu (EF-G and EF-Tu), initiation factor
2 (IF2), LepA, Era, Obg, ThdF/TrmE, Ffh, FtsY, EngA, and YchF.15
These 11 GTPases are vital for bacterial life, since they regulate the
cell cycle and distribution of DNA to daughter cells.16–19
Eukaryotic Rab GTPases are important regulators of different
steps of the pathways leading to phagosome maturation arrest.
Rab GTPases, in particular Rab5 and Rab7, regulate rate-limiting
steps leading to maintenance and self-preservation of Mycobacte-
rium within host macrophages (Figure 3).20 Apart from these,
Rab14 has also been identiﬁed as an important factor in
maintaining the phagosome maturation block.21 Another GTPase,
FtsZ, has been characterized as an assembling GTPase, which
functions in prokaryotic cell division. FtsZ antagonists disrupt its
assembling activity and cause lethality to a variety of bacteria.22ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Signiﬁcance of unique cell wall components ofMycobacterium tuberculosis
against the host immune system.
Figure 3. Role of Rab GTPases in phagosomematuration arrest: recruitment of Rab5
on the phagosome results in the formation of early endosome, but lack of Rab7
blocks its maturation into late endosome, ultimately leading to the inhibition of
phagosome lysosome fusion.
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Mycobacterium within the host macrophage.
2. Tuberculosis as the major problem we are facing today
TB remains a global puzzle in spite of effective chemotherapy,
the BCG vaccine, and the directly observed treatment, short-course
(DOTS) strategy for its treatment. TB is a leading cause of mortality
and morbidity and affects a third of the world’s current
population.2 Other Mycobacterium species such as Mycobacterium
bovis, Mycobacterium africanum, Mycobacterium canetti, and
Mycobacterium microti also cause TB, but are relatively less
common. Latent infection is the most common and signiﬁcant
stage, which if left untreated leads to death inmore than half of the
patients.2 The BCG vaccine is one of the world’s most widely used
vaccines, despite showing variable effectiveness in different
clinical trials. Treatment of TB employs anti-TB drugs to kill the
bacteria, such as rifampin and isoniazid. A long time duration
(around 6–12 months) is required to entirely eradicate Mycobac-
terium from the body.23 There are two stages in the infection
process: latent TB and active TB, which demand differentFigure 2. GTPase cycle depicting GTP binding proteins as molecular switch proteins
cycling between the active GTP-bound and inactive GDP-bound state.treatments. Latent TB is treated using a single drug, while active
TB is best treated using a combination of several drugs, to reduce
the development of antibiotic-resistant bacteria.24
Spontaneous mutations in M. tuberculosis H37Rv, incomplete
and inadequate treatment,25,26 poor administrative control on
purchase, irregular distribution of the drugs, and improper quality
control and bioavailability tests have led to the development of
MDR-TB.27 MDR-TB is resistant to rifampicin and isoniazid.27 The
DOTS strategy is a key factor involved in TB control.28 This strategy
is based upon clinical trials done in the 1970 s by the TB Research
Center, Chennai, India. Mismanagement and ignorance in relation
to treatment have led to the emergence of a new form of drug-
resistant TB known as XDR-TB.29 Based on the meeting of the
World Health Organization (WHO) XDR-TB task force, XDR-TB has
been deﬁned as TB caused by M. tuberculosis H37Rv resistant to at
least rifampicin and isoniazid among the ﬁrst-line anti-TB drugs
(MDR-TB), as well as resistance to any ﬂuoroquinolones, i.e.,
oﬂoxacin, ciproﬂoxacin, and levoﬂoxacin, and at least one of three
second-line anti-TB drugs, i.e., amikacin, kanamycin, and capreo-
mycin.30 The increasing antibiotic resistance of M. tuberculosis
H37Rv demands an urgent solution.
3. Mycobacterium tuberculosis—natural warriors
3.1. Unique cell wall structure
The cell wall structure of M. tuberculosis H37Rv has become
cynosure in the ﬁeld of research, as it is unique among prokaryotes
and is a major determinant of virulence for this bacterium. M.
tuberculosis H37Rv contains large amounts of glycolipid and is
especially rich in mycolic acid, making up approximately 60% of
the cell wall. The orientation of mycolic acids is perpendicular to
the plane of the membrane, creating a special lipid barrier, which
serves as the major factor contributing to the virulence of M.
tuberculosis H37Rv.
3 In addition to mycolic acid, other glycolipids
include LAM, PIM, phthiocerol dimycocerosate, cord factor/
dimycolyltrehalose, sulfolipids, and wax D.4 Mycolic acids prevent
an attack on Mycobacterium by cationic proteins, lysozymes, and
the oxygen radicals in the phagocytic granule. Cord factor is toxic
to mammalian cells and is also an inhibitor of polymorphonuclear
neutrophil (PMN) migration, an important effector mechanism in
the defense against external antigenic agents; cord factor is
produced abundantly in virulent strains of M. tuberculosis H37Rv.
Wax D in the cell envelope is the major component of Freund’s
complete adjuvant (CFA).
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and the most powerful protective antigen ofM. tuberculosis H37Rv.
It is a triad of related gene products. Antigen 85 is involved in
disease pathogenesis through its ﬁbronectin binding capacity.
These proteins act as mycolyltransferases and are involved in the
ﬁnal stages of mycobacterial cell wall assembly.5
LAM is also an important component of the cell wall and has
been shown to be involved in phagocytosis ofM. tuberculosisH37Rv
when ‘capped’ with short mannose oligosaccharides (ManLAM).4,5
ManLAM speciﬁcally inhibits the pathway dependent on phos-
phatidylinositol-3-kinase (PI3K) and phosphatidylinositol-3-phos-
phate (PI3P) binding effectors, and in this way inhibits phagosome
maturation (Figure 1).6 Porins in the mycobacterial cell wall show
strikingly different features from those of other bacteria and form a
sort of diffusion barrier that is 100–1000 times less permeable to
hydrophilic molecules than that of other bacteria like Escherichia
coli.7
3.2. Virulence factors
M. tuberculosis H37Rv has an inbuilt capacity to survive and
persist within a hostile environment and adverse conditions
created by the host defense system. It is able to manipulate
different host defense pathways and has the ability to actively
inhibit the killing of infected host cells by apoptosis.8 This
inhibition is caused by multiple genetic loci in M. tuberculosis
H37Rv. It has been observed that the anti-apoptosis activity is
attributable to the type 1 nicotinamide adenine dinucleotide
(NADH) dehydrogenase ofM. tuberculosis H37Rv, and is mainly due
to the subunit of this multicomponent complex encoded by the
nuoG gene. Experiments in the SCID (severe combined immuno-
deﬁciency) mouse model have shown that the expression of M.
tuberculosisH37Rv nuoG in non-pathogenic mycobacteria endowed
themwith the ability to inhibit apoptosis of infectedmacrophages,
and increased their virulence. Deletion of nuoG in M. tuberculosis
H37Rv destroyed its ability to inhibit macrophage apoptosis
resulting in reduced virulence. This distinctly shows the straight-
forward link between the nuoG virulence factor and inhibition of
macrophage apoptosis.8
Virulence also depends on the ability of Mycobacterium to
multiply in mammalian hosts. The erp gene encodes an exported
repetitive protein that causes multiplication of M. tuberculosis
H37Rv in cultured macrophages.
9
Parasitism of host macrophages by Mycobacterium is also a key
factor in inducing virulence. Macrophage infection byMycobacteri-
um is a schematic process involving adhesions and phagocytosis-
mediated entry into the host cell, ultimately leading to inhibition of
phagosome–lysosome fusion and resistance to free radicals. Several
approaches have been used from time to time to identify genes
involved in virulence. One such approach is signature-tagged
transposon mutagenesis, which has shown that mutants disrupted
in the ATP-binding cassette (ABC) transporter-encoding genes
Rv0986 and Rv0987 are impaired in their ability to bind to the host
cell.10 An mRNA differential display assay has revealed distinctions
between gene expression inM. tuberculosis H37Rv and its avirulent
mutant strain H37Ra. It was found that six cDNAs that were
expressed in H37Rvwere not expressed in H37Ra; these were cloned
and 10 inserts for each cDNA were sequenced, out of which six
inserts were highly homologous to the M. tuberculosis H37Rv gene.
Three of these genes, Rv2770c, Rv1345, and Rv0288, code for
members of the PPE (Pro–Pro–Glu) protein family, a plausible
polyketide synthase, and amember of the protein family containing
ESAT-6 (early secretory antigenic target). These genes have been
showntobeassociatedwithpathogenesis ofM. tuberculosisH37Rv.
11
M. tuberculosis H37Rv uses inositol as a precursor in the
production of its major thiol and lipoglycans. A mutant Mycobac-terium lacking the gene encoding inositol-1-phosphate synthase
(ino1), which catalyzes the ﬁrst step in inositol synthesis, is viable
only in the presence of high levels of exogenous inositol.12 M.
tuberculosis H37Rv possesses four genes encoding phospholipases
C, plcA, plcB, plcC, and plcD. Expression of these genes is up-
regulated during the ﬁrst 24 h of macrophage infection.13 M.
tuberculosis H37Rv uses fatty acids to persist inside the phagosome
of macrophages. The fadE28 gene was identiﬁed as a source of fatty
acids inside phagosomes, since the up-regulation of the fadE28
gene causes an elevation in fatty acids by increasing beta-
oxidation.14
3.3. Dormant nature of MTB
M. tuberculosis H37Rv latent bacilli are microorganisms that are
well known for their ability to tolerate the stressful conditions
produced by the immune system of the infected host against them.
M. tuberculosis H37Rv counterbalances the adverse conditions and
appears ‘silent’ to the immune system by slowing its metabolism
or becoming dormant.31 The dormant bacilli are a major problem
for TB treatment. Evidence from a murine model of TB has shown
that nitric oxide synthase is essential for the infection. It has also
been observed that oxygen and low, nontoxic concentrations of
nitric oxide (NO) competitively modulate the expression of a 48-
gene regulon, which is expressed in order to prepare bacilli for
persistence during long periods of dormancy. NO has been found to
be responsible for the reversible inhibition of aerobic respiration
and growth. This inhibition of respiration by NO production and
oxygen limitation within granulomas, suppress M. tuberculosis
H37Rv replication rates in individuals with latent TB.
32 Seminal
studies have shown that gradual depletion in oxygen concentra-
tions causes a non-replicating persistent stage characterized by
bacteriostasis and metabolic, chromosomal, and structural
changes in the dormant bacteria. A further reduction in oxygen
tension produces a more quiescent state, characterized by the
onset of sensitivity to metronidazole and resistance to other
antimicrobials. Studies have been focused on NO as an immune
factor that is able to suppress mycobacterial replication rates in
vivo and is involved in the initiation andmaintenance of the latent
state in conjunction with low tissue oxygen concentrations.33
3.4. GTPases as versatile signaling molecules
GTPases are regarded as molecular switch proteins based on
their special mode of action. Each protein is capable of selectively
binding and hydrolyzing guanosine triphosphate (GTP) in a cyclic
manner that activates and inactivates the GTPase protein
(Figure 2).15 These GTPases comprise a protein superfamily of
highly conserved molecular switches capable of performing a
diverse range of functions. GTPasesmake a signiﬁcant contribution
to different fundamental cellular processes, which vary between
prokaryotes and eukaryotes. In contrast to prokaryotes, eukaryotic
G-proteins, commonly known as heterotrimeric G-proteins,
consist of three subunits – a, b, and g. The G-domain is located
on the largest, i.e., a-subunit, forming a tightly associated protein
complex with the two other smaller subunits b and g. G-protein
coupled receptors act as the speciﬁc reaction partners of
heterotrimeric G-proteins. In the normal state the GTPase is
inactive, but upon receptor activation, the GTPase is activated by
the intracellular receptor domain, which in turn activates other
steps of the signal transduction pathway.16 One striking difference
between GTPases of prokaryotes and eukaryotes is that prokar-
yotes do not use GTPases in the sameway as eukaryotes to regulate
membrane signaling.19
Investigations and studies carried out to understand the role of
GTPases have revealed an important conserved feature of these
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with RNA or ribosomes. The GTPase passes through three
conformational states: initially the GTPase is not bound to any
nucleotide and is inactive; after binding to GTP it becomes active;
and after interaction with the target GTP it is hydrolyzed, resulting
in the inactivation of GTPase, with GDP bound to it. The empty
(inactivated) state is regenerated by interaction with another
factor that catalyses nucleotide release.19 Studies have recognized
G1, G2, G3, and G4 sequence motifs as the highly conserved
elements that are involved in speciﬁc interactions with the
guanine nucleotides and effector proteins. Of these motifs, G1, G3,
and G4 have been found to bind and hydrolyze GTP and also
interactwith cofactorMg2+.15 TheG2motif is known as the effector
domain, which undergoes a conformational change essential for
GTPase function.34,35 This particular motif is characteristic for each
subfamily of GTPases, since it is not conserved throughout the
GTPase superfamily. Bacterial GTPases are the principal regulators
of ribosome function and the distribution of DNA to daughter cells
following cell division.
Genome sequencing projects have demonstrated that bacteria
possess a core of 11 universally conserved GTPases, named EF-G
and EF-Tu, IF2, LepA, Era, Obg, ThdF/TrmE, Ffh, FtsY, EngA, and
YchF.36 Among all these GTPases, EF-G, EF-Tu, and IF2 are
multidomain GTPases with essential roles in the initiation and
elongation phases of translation. They bind to the site on the
ribosomes where their low intrinsic GTPase activities are strongly
induced. IF2, EF-G, EF-Tu, and RF3 are the four proteins belonging
to the GTPase superfamily that participate in bacterial biosynthe-
sis.17,18 Obg was discovered in Bacillus subtilis and has been
implicated in regulating sporulation, chromosome partitioning,
mycelium development, and the stress response. Studies have
shown that it is also involved in the initiation of chromosome
replication37 and the regulation of the phosphorylation state of
SpoOA, resulting in the initiation of sporulation. It promotes
binding of tRNA to the ribosomal P site during the initiation step of
translation.38,39 EF-Tu is involved in the delivery of an amino acyl-
tRNA to the A site and the formation of the peptide bond. EF-G
promotes translocation of the ribosome.40,41 LepA is universally
conserved among all bacterial GTPases.19,42 Era was ﬁrst described
in E. coli, and it has been postulated that the B. subtilis Era ortholog
functions in chromosome segregation.43,44 The 16 s RNA-bound
form of Era is an activator of cell division and the RNA free form is
an inactive state required for the termination of cell division. ThdF/
TrmE is an Era-like GTPase with a GTP binding domain and is
essential for the normal function of the protein synthesis
apparatus.19,45 EngA is a unique GTPase as it contains two GTP
binding domains arranged in tandem.36 It is thought to be involved
in ribosome assembly or stability. A myriad of experiments and
studies have been conducted on these GTPases from time to time,
and it has been observed that in all bacterial systems the core 11
GTPases are vital for life and for regulating ribosome function
directly or indirectly by transmitting signals, regulating the cell
cycle, DNA partitioning, and DNA segregation.19
4. GTPases as an attractive target
M. tuberculosis H37Rv, like other intracellular bacterial patho-
gens, has evolved highly specialized mechanisms to enter and
survive intracellularly within host macrophages. M. tuberculosis
H37Rv inhibits phagosome maturation and so remains protected
from degradative and bactericidal intracellular compartments,
lysozymes, and antigen-presenting organelles in the host phago-
cytic cells.20 Therefore phagosome maturation arrest is the central
power ofM. tuberculosis H37Rv and the cause of loopholes used by
M. tuberculosis H37Rv against the host defense system.Studies have shown that GTPases play a central role in
phagosome maturation arrest as described in a study highlighting
the role of Rab GTPases.46 GTP binding proteins of the Rab family
have been observed to regulate transport in the endocytic and
exocytic pathways and in conferring speciﬁcity of vesicle fusion.
Studies have shown that inhibition of phagosome maturation is
due to a block between the maturation phases controlled by the
early endocytic small GTPase Rab5 and the late endosomal small
GTPase Rab7 (Figure 3).46 Transport from the plasmamembrane to
early endosomes and the homotypic fusion of early endosomes is
controlled by Rab5. Rab4 is involved in trafﬁcking from the early
endosomes through the recycling pathway, whereas transport
from the early to late endosomes is controlled by Rab7. Rab5 is
known as a regulator of a rate-limiting step in early endosomal
fusion and this is responsible for the maintenance and self-
preservation of the early endosomal sorting compartment.
Mycobacteria are able to survive and multiply inside the
macrophage due to the lack of recruitment of Rab7.46
Recently it has been observed that phagosome maturation
arrest is due to a block in the PI3K-dependent trafﬁcking pathway
from the trans-Golgi network (TGN) to the phagosome.6 PI3K is
central to cell survival and protects cells from programmed cell
death and is important for regulating neutrophil function and
inﬂammatory processes. This block prevents the delivery of the
critical late endosomal and lysosomal effectors, such as V0-H
+-
ATPase subunits, and lysosomal hydrolases, such as cathepsin D, to
the M. tuberculosis H37Rv phagosome.
6
PI3P has been shown to play an essential role in several
signaling pathways and endocytic trafﬁc, and is generated on the
early endosomes via recruitment of PI3Ks, including hVPS34, by
the active Rab5. Two bacterial products produced by M.
tuberculosis H37Rv act on PI3P to inhibit phagosome maturation:
(1) LAM, the well known unique cell wall component of M.
tuberculosis H37Rv, prevents PI3P generation on phagosomes,
6 and
(2) the bacterial enzyme SapM acts as a PI3P phosphatase to
remove this lipid from phagosomes.47 Hence Mycobacterium
effectively blocks their delivery to lysosomes by inhibiting PI3P
action.
The mechanism behind modiﬁcation of Rabs associated with
phagosome maturation has been suggested. Rab22a, a member of
the group 5 Rabs, has been reported to accumulate on mycobacte-
rial phagosomes. It has also been shown to be responsible for
phagosomematuration arrest in an experiment that demonstrated
that reduced expression of this GTPase enhanced phagosome
maturation in phagosomes with live mycobacteria, while over-
expression of its mutant prevented phagosome maturation. From
this study it was concluded that Rab22a is noteworthy for the
regulation of Rab7 conversions on phagosomes and so in
phagosome maturation.21
The role of another GTPase, Rab14, has been shown by Kyei
et al., who observed the accumulation of Rab14 on phagosomes
harboring live bacteria as demonstrated by 4-Dmicroscopy.22 This
study also reported the evaluative role of Rab14 inmaintaining the
phagosome maturation block. They considered that the recruit-
ment of Rab14 as a knockdown by SiRNA or over-expression of
Rab14 dominant negativemutants (Rab14S25N and Rab140N125I)
relinquished the maturation block and caused phagosome
maturation into phagolysosomes. These ﬁndings suggest that M.
tuberculosis target Rab GTPase functions to colonize and persist
within phagosomes and remain protected from the host defense
system, hence Rab GTPases serve as potential drug targets against
M. tuberculosis H37Rv.
Apart from Rabs, another GTPase has also been reported – FtsZ;
this is an assembling GTPase that is a prokaryotic cell division
protein.48 FtsZ assembles into a cytokinetic ring structure essential
for cell division in prokaryotic cells. FtsZ functions in a manner
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protoﬁlaments in the presence of GTP accompanied by GTP
hydrolysis after polymer assembly, as well as directing the
formation of the septosome between daughter cells. Margalit
et al. identiﬁed zantrins as compounds that inhibit FtsZ GTPase
either by destabilizing the FtsZ protoﬁlaments or inducing ﬁlament
hyper-stability through increased lateral association; in this way
they disrupt FtsZ ring assembly in E. coli and cause lethality to a
variety of bacteria in broth cultures.48 This clearly shows that FtsZ
antagonists can potentially serve as a source for the development
of new broad-spectrum antibacterial drugs, also able to target M.
tuberculosis H37Rv. It is an attractive and novel therapeutic target
for the development of new antibiotics.49
5. Conclusions
The development of anti-TB drugs has been the topic of
discussion since the introduction of BCG and DOTS. As the rate of
development of new drugs has increased, antibiotic resistance in
the strain has also increased, leading to the emergence of MDR-TB
and XDR-TB. This increasing antibiotic resistance demands a novel
way to design drugs active against TB. Signaling molecule GTPases
such as Era, Obg, LepA, and FtsZ are vital for growth and
development and for speciﬁc cellular functions in the bacteria.
In view of all the observations that have shown a crucial role for
GTPases in cell division, the cell cycle, bacterial biosynthesis, gene
translation, distribution of DNA to daughter cells, and sporulation,
it is concluded that a more comprehensive approach is needed to
design a new generation of drugs for TB using GTPases. The most
important factor contributing to the ability of the pathogen to
survive host inﬂammatory mediators and antibiotic treatment is
its dormant state.
5.1. Future perspectives
The establishment of the latent state requires unique
regulatory pathways and GTPases, as shown by eukaryotic
Rab GTPases in the survival and persistence of M. tuberculosis
within host macrophages. This highlights the possible use of
GTPases as novel drug targets against TB. Previous studies have
shown an important role of GTP-binding proteins in ribosome
assembly and DNA segregation. GTP binding proteins can be
deleted in order to understand their function. This study serves
as a basis to understand the ribosome-associated function of Era,
Obg, LepA, EngA, and other GTPases in M. tuberculosis through
polysome proﬁling. It will require a huge effort to realize the
signiﬁcance of these GTPases in the physiology of M. tuberculosis
and to design an effective drug against the recalcitrant form of
M. tuberculosis.
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